BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li Z, Zhang H, Wang X, Wang Q, Xue J, Shi Y, Wang M, Wang G, Zhang J. Identification of cuproptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in breast cancer. Front Immunol 2022;13:996836. [DOI: 10.3389/fimmu.2022.996836] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Li D, Shi Z, Liu X, Jin S, Chen P, Zhang Y, Chen G, Fan X, Yang J, Lin H. Identification and development of a novel risk model based on cuproptosis-associated RNA methylation regulators for predicting prognosis and characterizing immune status in hepatocellular carcinoma. Hepatol Int 2023. [PMID: 36598701 DOI: 10.1007/s12072-022-10460-2] [Reference Citation Analysis]
2 Xie M, Cheng B, Yu S, He Y, Cao Y, Zhou T, Han K, Dai R, Wang R. Cuproptosis-Related MiR-21-5p/FDX1 Axis in Clear Cell Renal Cell Carcinoma and Its Potential Impact on Tumor Microenvironment. Cells 2022;12. [PMID: 36611966 DOI: 10.3390/cells12010173] [Reference Citation Analysis]
3 Li Z, Shi Y, Wu L, Zhang H, Xue J, Li W, Wang X, Zhang L, Wang Q, Duo L, Wang M, Wang G. Establishment and verification of a nomogram to predict tumor-specific mortality risk in triple-negative breast cancer: a competing risk model based on the SEER cohort study. Gland Surg 2022;11:1961-75. [PMID: 36654948 DOI: 10.21037/gs-22-650] [Reference Citation Analysis]
4 Wang L, Yao B, Yang J, Tian Z, He J. Construction of a novel cuproptosis-related gene signature for predicting prognosis and estimating tumor immune microenvironment status in papillary thyroid carcinoma. BMC Cancer 2022;22:1131. [DOI: 10.1186/s12885-022-10175-5] [Reference Citation Analysis]